Ronapreve
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Phil Taylor
Alzheimer's disease, gantenerumab, neurology, Roche, Ronapreve, Sales and Marketing
0 Comment
X
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
https://pharmaphorum.com/news/roche-talking-to-fda-as-alzheimers-drug-moves-towards-2022-readout/